{"data":[{"accessionNo":"0002012383-26-003823","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"OPUS GENETICS INC","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5044847,"percentOfClass":6.1,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-352641","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":9233710,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-352641","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":9233710,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-352641","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":9233710,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001727492-26-000020","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Caligan Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6077084,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001727492-26-000020","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"JOHNSON DAVID EDWARD","reportingCik":null,"personType":"HC,IN","sharesOwned":6077084,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001172661-26-003425","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5480210,"percentOfClass":6.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001172661-26-003425","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":5480210,"percentOfClass":6.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001172661-26-003425","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BALYASNY ASSET MANAGEMENT L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5480210,"percentOfClass":6.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001172661-26-003425","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5480210,"percentOfClass":6.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001172661-26-003425","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":5480210,"percentOfClass":6.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-233062","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-18","reportingPerson":"Foundation Fighting Blindness Retinal Degeneration Fund","reportingCik":"0002042266","personType":"CO,OO","sharesOwned":3792171,"percentOfClass":4.66,"filedAt":"2026-05-20","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-233062","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-18","reportingPerson":"Foundation Fighting Blindness, Inc.","reportingCik":"0002042532","personType":"CO","sharesOwned":3792171,"percentOfClass":4.66,"filedAt":"2026-05-20","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-226555","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":8830145,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-226555","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8830145,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-226555","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":8830145,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001727492-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"JOHNSON DAVID EDWARD","reportingCik":null,"personType":"HC,IN","sharesOwned":6075028,"percentOfClass":8.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001727492-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Caligan Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6075028,"percentOfClass":8.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-225195","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":5110373,"percentOfClass":7.18,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-225195","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5110373,"percentOfClass":7.18,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-225195","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":5110373,"percentOfClass":7.18,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-225195","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5110373,"percentOfClass":7.18,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-225195","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Balyasny Asset Management L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5110373,"percentOfClass":7.18,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-062694","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":4839225,"percentOfClass":6.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-062694","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":4839225,"percentOfClass":6.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-062694","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":4839225,"percentOfClass":6.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0000919574-26-002950","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":6029775,"percentOfClass":8.47,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0000919574-26-002950","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":6029775,"percentOfClass":8.47,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0000919574-26-002950","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":6029775,"percentOfClass":8.47,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"CAVU ADVISORS, LLC","reportingCik":null,"personType":"PN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"LESLIE W. KREIS","reportingCik":null,"personType":"IN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"AARON G.L. FLETCHER","reportingCik":null,"personType":"IN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"CAVU MANAGEMENT, LP","reportingCik":null,"personType":"PN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS EQUITY PARTNERS III, LP","reportingCik":null,"personType":"PN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS CAPITAL MANAGEMENT, LP","reportingCik":null,"personType":"PN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS ADVISORS GP, LLC","reportingCik":null,"personType":"PN","sharesOwned":3683429,"percentOfClass":4.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS FUND III QP, LP","reportingCik":null,"personType":"PN","sharesOwned":2801953,"percentOfClass":3.44,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS FUND III NT, LP","reportingCik":null,"personType":"PN","sharesOwned":450811,"percentOfClass":0.55,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001791917-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":"67577R102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-12","reportingPerson":"BIOS FUND III, LP","reportingCik":null,"personType":"PN","sharesOwned":430665,"percentOfClass":0.53,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-054534","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":7174154,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-054534","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":7174154,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-054534","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":7174154,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-052859","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5110373,"percentOfClass":7.41,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-052859","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":5110373,"percentOfClass":7.41,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-052859","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Balyasny Asset Management L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5110373,"percentOfClass":7.41,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-052859","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5110373,"percentOfClass":7.41,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-26-052859","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001228627","issuerName":"Opus Genetics Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":5110373,"percentOfClass":7.41,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-015341","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":7123506,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-015341","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":7123506,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001104659-26-015341","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":7123506,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-25-316569","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-09","reportingPerson":"Foundation Fighting Blindness Retinal Degeneration Fund","reportingCik":"0002042266","personType":"CO,OO","sharesOwned":5492171,"percentOfClass":8,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/ird"},{"accessionNo":"0001193125-25-316569","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001228627","issuerName":"Opus Genetics, Inc.","ticker":"IRD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-09","reportingPerson":"Foundation Fighting Blindness, Inc.","reportingCik":"0002042532","personType":"CO","sharesOwned":5492171,"percentOfClass":8,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/ird"}],"updatedAt":"2026-11-03T23:27:06.642Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ird","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}